Literature DB >> 20638853

Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system.

Shreya Datta1, Megan E Bucks, Dipankar Koley, Pei Xin Lim, Sergey N Savinov.   

Abstract

Upregulation of structurally homologous oncoproteins Hdm2 and Hdmx has been linked to the depletion or inactivation of their common regulation target the tumor suppressor p53 protein leading to the progression of cancer. The restoration of the p53 function, rendered suppressed or dormant by these negative regulators, establishes, therefore, a unique opportunity for a targeted induction of apoptosis in cancers that retain wild-type p53. While several small molecules have been reported to rescue the tumor suppressor by antagonizing the Hdm2-p53 interaction, these agents displayed limited application scope by being ineffective in tumors enriched with active Hdmx. Here, we describe the use of a genetic selection system and encoded library of conformationally pre-organized peptides to perform functional profiling of each regulator revealing specific recognition features that guide the antagonism of Hdm2-p53 and Hdmx-p53 interactions. Structure-activity relationship analysis of the most effective leads identified functional and structural elements mediating selective recognition of the two structurally related regulators, while providing convenient starting points for further activity optimization. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638853      PMCID: PMC2922946          DOI: 10.1016/j.bmc.2010.06.053

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  42 in total

1.  Production of cyclic peptides and proteins in vivo.

Authors:  C P Scott; E Abel-Santos; M Wall; D C Wahnon; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  A two-hybrid system based on chimeric operator recognition for studying protein homo/heterodimerization in Escherichia coli.

Authors:  G Di Lallo; L Castagnoli; P Ghelardini; L Paolozzi
Journal:  Microbiology       Date:  2001-06       Impact factor: 2.777

3.  MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin.

Authors:  Baoli Hu; Daniele M Gilkes; Bilal Farooqi; Said M Sebti; Jiandong Chen
Journal:  J Biol Chem       Date:  2006-08-11       Impact factor: 5.157

Review 4.  ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.

Authors:  Erik Meulmeester; Yaron Pereg; Yosef Shiloh; Aart G Jochemsen
Journal:  Cell Cycle       Date:  2005-09-29       Impact factor: 4.534

5.  Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions.

Authors:  Chong Li; Marzena Pazgier; Changqing Li; Weirong Yuan; Min Liu; Gang Wei; Wei-Yue Lu; Wuyuan Lu
Journal:  J Mol Biol       Date:  2010-03-10       Impact factor: 5.469

6.  A systematic method for identifying small-molecule modulators of protein-protein interactions.

Authors:  Alexander R Horswill; Sergey N Savinov; Stephen J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-21       Impact factor: 11.205

Review 7.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 8.  MDM2 and MDM4: p53 regulators as targets in anticancer therapy.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Int J Biochem Cell Biol       Date:  2007-04-08       Impact factor: 5.085

Review 9.  MDM2 and prognosis.

Authors:  Kenan Onel; Carlos Cordon-Cardo
Journal:  Mol Cancer Res       Date:  2004-01       Impact factor: 5.852

10.  Comparative study of the p53-mdm2 and p53-MDMX interfaces.

Authors:  V Böttger; A Böttger; C Garcia-Echeverria; Y F Ramos; A J van der Eb; A G Jochemsen; D P Lane
Journal:  Oncogene       Date:  1999-01-07       Impact factor: 9.867

View more
  2 in total

Review 1.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Identification of selective protein-protein interaction inhibitors using efficient in silico peptide-directed ligand design.

Authors:  Andrew M Beekman; Marco M D Cominetti; Samuel J Walpole; Saurabh Prabhu; Maria A O'Connell; Jesus Angulo; Mark Searcey
Journal:  Chem Sci       Date:  2019-03-22       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.